Dyspep

Dyspep Use In Pregnancy & Lactation

simeticone

Manufacturer:

Geno

Distributor:

Nebula

Marketer:

Mascots
Full Prescribing Info
Use In Pregnancy & Lactation
U.S. Food and Drug Administration's Pregnancy Category B by one manufacturer and category C by another source (Briggs et al, 1998).
See Drug Consult reference: "PREGNANCY RISK CATEGORIES".
There have been no published reports linking Simethicone with congenital defects. However, an unpublished surveillance study of 229,101 completed pregnancies identified 248 newborns exposed to Simethicone during the first trimester, in which 14 (5.6%) major birth defects were observed and 11 were expected. Of the 6 defect categories, only the cardiovascular defects suggested possible association with Simethicone; specific data for the individual categories were as follows (observed/expected): cardiovascular 6/2; oral clefts 0/0.5; spina bifida 0/0; Polydactyly 2/1; limb reduction defects 0/0.5; and hypospadias 1/0.5 (Briggs et al, 1998).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in